Subudhi, S. K., Siddiqui, B. A., Aparicio, A. M., Yadav, S. S., Basu, S., Chen, H., . . . Sharma, P. (2021). Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment. Journal for immunotherapy of cancer, 9(10), . doi:10.1136/jitc-2021-002919
Chicago ZitierstilSubudhi, Sumit K., et al. "Combined CTLA-4 and PD-L1 Blockade in Patients With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Is Associated With Increased Myeloid and Neutrophil Immune Subsets in the Bone Microenvironment." Journal for Immunotherapy of Cancer 9, no. 10 (2021).
MLA ZitierstilSubudhi, Sumit K., et al. "Combined CTLA-4 and PD-L1 Blockade in Patients With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Is Associated With Increased Myeloid and Neutrophil Immune Subsets in the Bone Microenvironment." Journal for Immunotherapy of Cancer 9.10 (2021).